After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
CONTACT: Rick Giles, +1-720-437-6500
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Trade-Ideas LLC identified Ampio Pharmaceuticals (AMPE) as a weak on high relative volume candidate
Ampio Pharma (AMPE) stock is sharply lower this afternoon following a phase 3 trial for its osteoarthritis pain treatment.
Ampio Pharmaceuticals (AMPE) shares are up over 10% after the company received Special Protocol Assessment from the FDA.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.